Mar. Drugs 2014, 12(6), 3416-3448; doi:10.3390/md12063416

Metabolomic Tools for Secondary Metabolite Discovery from Marine Microbial Symbionts

1,* email, 1email, 1email, 1email, 1,2email, 1email, 2email, 2email, 2email and 1,* email
Received: 6 March 2014; in revised form: 20 May 2014 / Accepted: 20 May 2014 / Published: 5 June 2014
(This article belongs to the Special Issue Metabolomics - Applications in Marine Natural Products Chemistry)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Marine invertebrate-associated symbiotic bacteria produce a plethora of novel secondary metabolites which may be structurally unique with interesting pharmacological properties. Selection of strains usually relies on literature searching, genetic screening and bioactivity results, often without considering the chemical novelty and abundance of secondary metabolites being produced by the microorganism until the time-consuming bioassay-guided isolation stages. To fast track the selection process, metabolomic tools were used to aid strain selection by investigating differences in the chemical profiles of 77 bacterial extracts isolated from cold water marine invertebrates from Orkney, Scotland using liquid chromatography-high resolution mass spectrometry (LC-HRMS) and nuclear magnetic resonance (NMR) spectroscopy. Following mass spectrometric analysis and dereplication using an Excel macro developed in-house, principal component analysis (PCA) was employed to differentiate the bacterial strains based on their chemical profiles. NMR 1H and correlation spectroscopy (COSY) were also employed to obtain a chemical fingerprint of each bacterial strain and to confirm the presence of functional groups and spin systems. These results were then combined with taxonomic identification and bioassay screening data to identify three bacterial strains, namely Bacillus sp. 4117, Rhodococcus sp. ZS402 and Vibrio splendidus strain LGP32, to prioritize for scale-up based on their chemically interesting secondary metabolomes, established through dereplication and interesting bioactivities, determined from bioassay screening.
Keywords: metabolomics; dereplication; symbiotic bacteria; mass spectrometry; NMR; multivariate analysis; metabolic profiling
PDF Full-text Download PDF Full-Text [1484 KB, Updated Version, uploaded 10 June 2014 17:10 CEST]
The original version is still available [1484 KB, uploaded 5 June 2014 08:26 CEST]

Export to BibTeX |

MDPI and ACS Style

Macintyre, L.; Zhang, T.; Viegelmann, C.; Martinez, I.J.; Cheng, C.; Dowdells, C.; Abdelmohsen, U.R.; Gernert, C.; Hentschel, U.; Edrada-Ebel, R. Metabolomic Tools for Secondary Metabolite Discovery from Marine Microbial Symbionts. Mar. Drugs 2014, 12, 3416-3448.

AMA Style

Macintyre L, Zhang T, Viegelmann C, Martinez IJ, Cheng C, Dowdells C, Abdelmohsen UR, Gernert C, Hentschel U, Edrada-Ebel R. Metabolomic Tools for Secondary Metabolite Discovery from Marine Microbial Symbionts. Marine Drugs. 2014; 12(6):3416-3448.

Chicago/Turabian Style

Macintyre, Lynsey; Zhang, Tong; Viegelmann, Christina; Martinez, Ignacio J.; Cheng, Cheng; Dowdells, Catherine; Abdelmohsen, Usama R.; Gernert, Christine; Hentschel, Ute; Edrada-Ebel, RuAngelie. 2014. "Metabolomic Tools for Secondary Metabolite Discovery from Marine Microbial Symbionts." Mar. Drugs 12, no. 6: 3416-3448.

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert